New methods for activation of kinases and kinase circuits in living cells.
New methods for activation of kinases and kinase circuits in living cells.
批准号:
8243734
负责人:
ANDREI V KARGINOV
金额:
$20.81万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-07-01 至 2014-06-30
关键词:
AffectBindingBiologicalBiological ModelsBiological ProcessCCI-779CalcineurinCatalytic DomainCell Surface ExtensionsCellsDependenceDevelopmentDimerizationDiseaseDoseEngineeringEventFK506Family memberFocal Adhesion Kinase 1Focal AdhesionsHeterodimerizationHumanKineticsLeadLifeLightLocationMAPK14 geneMediatingMembraneMethodsOrganOutcomePathway interactionsPhenotypePhosphotransferasesPositioning AttributeProtein EngineeringProtein KinaseReagentRegulationResolutionRoleScientistSignal PathwaySirolimusSpecificitySystemTacrolimus Binding ProteinsTechniquesTechnologyTestingTimeWorkanalogbasecell behaviorcell motilityinhibitor/antagonistmetaplastic cell transformationmutantnovel strategiesprotein complexsrc-Family Kinasestool
中文摘要
描述(由申请人提供):在活细胞中精确定时和定位操纵蛋白激酶活性仍然很困难。此外,目前在大多数生物学研究中,仅在选定的蛋白质复合物中靶向操纵激酶活性是不可能的。我们最近开发了一种新的普遍适用的雷帕霉素调节(RapR)激活激酶的方法,并成功地将其应用于来自两种不同类型的三种激酶,tyr和ser/thr激酶(FAK, Src和p38)。在这里,我们建议利用RapR技术开发新的广泛适用的方法来选择性调节活细胞中高度同源的激酶,以及仅当激酶处于特定蛋白质复合物中时靶向激活它们。我们还将利用笼型雷帕霉素实现光介导的激酶局部调控。这些方法将用于确定不同Src家族激酶的作用。这些高度同源的激酶可以很好地测试新方法的特异性,并将提供新的能力来回答以前难以解决的问题。局部激活将用于探索调节细胞突起和极化的通路的时空调节。
英文摘要
DESCRIPTION (provided by applicant): It remains difficult to manipulate protein kinase activity with precise timing and localization in living cells. Furthermore, targeted manipulation of kinase activity only in selected protein complexes is currently impossible for the majority of biological studies. We have recently developed a new generally applicable method for rapamycin-regulated (RapR) activation of kinases and successfully applied it to three kinases from two different classes, tyr and ser/thr kinases (FAK, Src, and p38). Here, we propose to employ RapR technology to develop new broadly applicable methods for selective regulation of highly homologous kinases in living cells, and targeted activation of kinases only when they are in specific protein complexes. We will also achieve light- mediated localized regulation of kinases using caged rapamycin. These methods will be applied to identify the roles of different Src family kinases. These highly homologous kinases serve as a good test of the specificity of the new approaches and will provide new capabilities to answer previously intractable questions. Localized activation will be used to probe the spatio-temporal regulation of pathways modulating cell protrusion and polarization.
PUBLIC HEALTH RELEVANCE: The proposed project is focused on the development of new tools for targeted manipulation and interrogation of specific signaling pathways in live cells. In particular, the work will enable scientists to turn on kinases, an important class of regulatory molecule, in precise places and times in cells. These new approaches will allow scientists to identify biological processes critical for normal development and function of human organs as well as pathological events leading to disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Optogenetic Control of Tumor Initiation and Tumor Progression in vivo
-
批准号:10640927
-
项目类别:
-
资助金额:$38.09万
-
财政年份:2022
-
负责人:ANDREI V KARGINOV
-
依托单位:
Regulation of endothelial cell invasion, migration and cell junction plasticity
-
批准号:10406685
-
项目类别:
-
资助金额:$39.98万
-
财政年份:2022
-
负责人:ANDREI V KARGINOV
-
依托单位:
Optogenetic Control of Tumor Initiation and Tumor Progression in vivo
-
批准号:10413468
-
项目类别:
-
资助金额:$40.36万
-
财政年份:2022
-
负责人:ANDREI V KARGINOV
-
依托单位:
Regulation of endothelial cell invasion, migration and cell junction plasticity
-
批准号:10685981
-
项目类别:
-
资助金额:$39.98万
-
财政年份:2022
-
负责人:ANDREI V KARGINOV
-
依托单位:
Synthetic Biology and Optogenetics Core
-
批准号:10701925
-
项目类别:
-
资助金额:$31.88万
-
财政年份:2021
-
负责人:ANDREI V KARGINOV
-
依托单位:
Synthetic Biology and Optogenetics Core
-
批准号:10170860
-
项目类别:
-
资助金额:$31.88万
-
财政年份:2021
-
负责人:ANDREI V KARGINOV
-
依托单位:
Synthetic Biology and Optogenetics Core
-
批准号:10491052
-
项目类别:
-
资助金额:$31.88万
-
财政年份:2021
-
负责人:ANDREI V KARGINOV
-
依托单位:
Optogenetic tools for the dissection of oncogenic signaling mediated by kinases
-
批准号:9891973
-
项目类别:
-
资助金额:$18.29万
-
财政年份:2018
-
负责人:ANDREI V KARGINOV
-
依托单位:
Src-mediated pathways regulating adherens junction assembly.
-
批准号:10166863
-
项目类别:
-
资助金额:$31.38万
-
财政年份:2017
-
负责人:ANDREI V KARGINOV
-
依托单位:
Src-mediated pathways regulating adherens junction assembly.
-
批准号:9310733
-
项目类别:
-
资助金额:$31.38万
-
财政年份:2017
-
负责人:ANDREI V KARGINOV
-
依托单位:
New methods for activation of kinases and kinase circuits in living cells.
-
批准号:8469837
-
项目类别:
-
资助金额:$16.3万
-
财政年份:2012
-
负责人:ANDREI V KARGINOV
-
依托单位:
Macromolecular Engineering
-
批准号:9151428
-
项目类别:
-
资助金额:$28.46万
-
财政年份:--
-
负责人:ANDREI V KARGINOV
-
依托单位:
Macromolecular Engineering
-
批准号:9324307
-
项目类别:
-
资助金额:$28.46万
-
财政年份:--
-
负责人:ANDREI V KARGINOV
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: